1. Home
  2. WPRT vs MRSN Comparison

WPRT vs MRSN Comparison

Compare WPRT & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WPRT
  • MRSN
  • Stock Information
  • Founded
  • WPRT 1995
  • MRSN 2001
  • Country
  • WPRT Canada
  • MRSN United States
  • Employees
  • WPRT N/A
  • MRSN N/A
  • Industry
  • WPRT Industrial Machinery/Components
  • MRSN Biotechnology: Pharmaceutical Preparations
  • Sector
  • WPRT Industrials
  • MRSN Health Care
  • Exchange
  • WPRT Nasdaq
  • MRSN Nasdaq
  • Market Cap
  • WPRT 49.9M
  • MRSN 42.9M
  • IPO Year
  • WPRT 1995
  • MRSN 2017
  • Fundamental
  • Price
  • WPRT $4.02
  • MRSN $0.31
  • Analyst Decision
  • WPRT Buy
  • MRSN Strong Buy
  • Analyst Count
  • WPRT 3
  • MRSN 5
  • Target Price
  • WPRT $6.33
  • MRSN $5.75
  • AVG Volume (30 Days)
  • WPRT 30.0K
  • MRSN 3.8M
  • Earning Date
  • WPRT 08-11-2025
  • MRSN 08-12-2025
  • Dividend Yield
  • WPRT N/A
  • MRSN N/A
  • EPS Growth
  • WPRT N/A
  • MRSN N/A
  • EPS
  • WPRT N/A
  • MRSN N/A
  • Revenue
  • WPRT $295,680,000.00
  • MRSN $34,006,000.00
  • Revenue This Year
  • WPRT N/A
  • MRSN N/A
  • Revenue Next Year
  • WPRT N/A
  • MRSN $1.03
  • P/E Ratio
  • WPRT N/A
  • MRSN N/A
  • Revenue Growth
  • WPRT N/A
  • MRSN N/A
  • 52 Week Low
  • WPRT $2.50
  • MRSN $0.26
  • 52 Week High
  • WPRT $6.20
  • MRSN $2.83
  • Technical
  • Relative Strength Index (RSI)
  • WPRT 78.18
  • MRSN 43.69
  • Support Level
  • WPRT $3.06
  • MRSN $0.35
  • Resistance Level
  • WPRT $4.15
  • MRSN $0.41
  • Average True Range (ATR)
  • WPRT 0.18
  • MRSN 0.03
  • MACD
  • WPRT 0.04
  • MRSN 0.00
  • Stochastic Oscillator
  • WPRT 86.17
  • MRSN 8.44

About WPRT Westport Fuel Systems Inc

Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

Share on Social Networks: